company background image
SYK logo

Stryker NYSE:SYK Stock Report

Last Price

US$378.22

Market Cap

US$144.4b

7D

3.6%

1Y

15.2%

Updated

04 May, 2025

Data

Company Financials +

Stryker Corporation

NYSE:SYK Stock Report

Market Cap: US$144.4b

SYK Stock Overview

Operates as a medical technology company. More details

SYK fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance1/6
Financial Health4/6
Dividends4/6

Rewards

Earnings are forecast to grow 14.14% per year

Risk Analysis

Large one-off items impacting financial results

Has a high level of debt


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

SYK logo
Stryker
AN
AnalystConsensusTarget
Consensus Narrative from 28 Analysts

Acquisition Of Inari Medical Will Expand Opportunities In $15 Billion Thrombectomy Market

Key Takeaways The acquisition of Inari Medical and divestment of the Spinal Implants business aim to realign Stryker’s focus towards high-growth, high-margin segments. Ongoing technological investments and international expansion, particularly in emerging markets, are key strategies for revenue and margin growth enhancement.
View narrative
US$421.86
FV
10.3% undervalued intrinsic discount
8.06%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
34users have followed this narrative
3 days ago author updated this narrative
SYK logo
Stryker
TO
Tokyo
Community Contributor

Investing in Stryker (SYK) should be an easy ride

Investing in Stryker (SYK) should be an easy ride Key “Take aways”: - Solid balance sheet - Earnings recovered, with positive outlook. - SYK is fair priced.
View narrative
US$323.52
FV
16.9% overvalued intrinsic discount
6.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
10 months ago author updated this narrative
View Stryker Community

Stryker Corporation Competitors

Boston Scientific

NYSE:BSX

US$155.2b

Intuitive Surgical

NasdaqGS:ISRG

US$185.4b

Medtronic

NYSE:MDT

US$108.8b

Abbott Laboratories

NYSE:ABT

US$227.7b

Price History & Performance

Summary of share price highs, lows and changes for Stryker
Historical stock prices
Current Share PriceUS$378.22
52 Week HighUS$406.19
52 Week LowUS$314.93
Beta0.94
1 Month Change9.38%
3 Month Change-3.30%
1 Year Change15.15%
3 Year Change57.54%
5 Year Change96.91%
Change since IPO69,725.19%

Recent News & Updates

Increases to CEO Compensation Might Be Put On Hold For Now at Stryker Corporation (NYSE:SYK)

May 02
Increases to CEO Compensation Might Be Put On Hold For Now at Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Has A Rock Solid Balance Sheet

May 01
Stryker (NYSE:SYK) Has A Rock Solid Balance Sheet

Calculating The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Apr 07
Calculating The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Recent updates

Increases to CEO Compensation Might Be Put On Hold For Now at Stryker Corporation (NYSE:SYK)

May 02
Increases to CEO Compensation Might Be Put On Hold For Now at Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Has A Rock Solid Balance Sheet

May 01
Stryker (NYSE:SYK) Has A Rock Solid Balance Sheet

Calculating The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Apr 07
Calculating The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker Corporation's (NYSE:SYK) Share Price Matching Investor Opinion

Mar 16
Stryker Corporation's (NYSE:SYK) Share Price Matching Investor Opinion

Is Stryker Corporation (NYSE:SYK) Potentially Undervalued?

Feb 26
Is Stryker Corporation (NYSE:SYK) Potentially Undervalued?

There May Be Some Bright Spots In Stryker's (NYSE:SYK) Earnings

Feb 05
There May Be Some Bright Spots In Stryker's (NYSE:SYK) Earnings

Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?

Jan 27

Here's Why We Think Stryker (NYSE:SYK) Is Well Worth Watching

Jan 17
Here's Why We Think Stryker (NYSE:SYK) Is Well Worth Watching

Stryker: Starting 2025 With A Bolt-On Deal For Inari Medical

Jan 08

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Dec 26
We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation: A Wide-Moat Medical Device Company, But Overvalued

Dec 24

Stryker (NYSE:SYK) Is Paying Out A Larger Dividend Than Last Year

Dec 13
Stryker (NYSE:SYK) Is Paying Out A Larger Dividend Than Last Year

Investor Optimism Abounds Stryker Corporation (NYSE:SYK) But Growth Is Lacking

Dec 03
Investor Optimism Abounds Stryker Corporation (NYSE:SYK) But Growth Is Lacking

At US$386, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Nov 21
At US$386, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Oct 16

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Oct 10
We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Sep 29
A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Sep 18
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Sep 01
We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21
Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

Jul 11
Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jun 30
A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19
Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Jun 16
The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Jun 05
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: Margin Gains Should Drive Upside

May 31

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

May 25
Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

May 14
Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

Stryker: A Great Company At An Expensive Price

Apr 05

Shareholder Returns

SYKUS Medical EquipmentUS Market
7D3.6%1.5%2.9%
1Y15.2%8.3%10.0%

Return vs Industry: SYK exceeded the US Medical Equipment industry which returned 8.3% over the past year.

Return vs Market: SYK exceeded the US Market which returned 10% over the past year.

Price Volatility

Is SYK's price volatile compared to industry and market?
SYK volatility
SYK Average Weekly Movement4.1%
Medical Equipment Industry Average Movement9.2%
Market Average Movement7.8%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market4.1%

Stable Share Price: SYK has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: SYK's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194153,000Kevin Lobowww.stryker.com

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.

Stryker Corporation Fundamentals Summary

How do Stryker's earnings and revenue compare to its market cap?
SYK fundamental statistics
Market capUS$144.36b
Earnings (TTM)US$2.86b
Revenue (TTM)US$23.22b

50.5x

P/E Ratio

6.2x

P/S Ratio

Is SYK overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SYK income statement (TTM)
RevenueUS$23.22b
Cost of RevenueUS$8.20b
Gross ProfitUS$15.02b
Other ExpensesUS$12.16b
EarningsUS$2.86b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)7.49
Gross Margin64.70%
Net Profit Margin12.31%
Debt/Equity Ratio68.7%

How did SYK perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

44%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 02:17
End of Day Share Price 2025/05/02 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Stryker Corporation is covered by 72 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Richard PurkissAtlantic Equities LLP
Jeffrey JohnsonBaird